RxDoctor Payments Data

Todd Mendelson, MD

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1902048291

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 49.4% of the total. Reporting peaked in 2020 at $7,112 and has fallen 96.5% since, to $252 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in PA, where the typical reported total is $15,643.

$15,137in general payments, 2019–2025

Across 165 payments — averaging $91.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Medical Device Business Services, Inc.$2K
  • Abbott$2K
  • Biosense Webster, Inc.$2K
  • Boston Scientific$638
  • Impulse Dynamics (USA) Inc.$303
  • plus $785 from 13 others
$28,842in research payments, 2019–2025

Across 17 payments — averaging $1696.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$29K

What the payments were for

  • Speaking & faculty fees$5,50036%
  • Travel & lodging$3,40022%
  • Food & beverage$6,21641%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,137 in reported general payments places this provider in the 45th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$249,933
Medicare patients
898
Services billed
2,781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban200$231,036
XareltoRivaroxaban74$101,517
Dofetilide60$17,537
Metoprolol Succinate105$1,814
Amiodarone Hcl79$1,534
Flecainide Acetate38$1,455
SotalolSotalol Hcl60$1,087
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$500
Atorvastatin Calcium34$486
Propranolol Hcl ErPropranolol Hcl13$480
Metoprolol Tartrate48$451
Propranolol Hcl14$413
Losartan Potassium23$244
Rosuvastatin Calcium17$241
Lisinopril15$228

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →